COVID-19

Hemostemix Announces First Sales Orders for ACP-01

Calgary, Alberta--(Newsfile Corp. - January 29, 2025) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company")…

1 year ago

Danaher Reports Fourth Quarter and Full Year 2024 Results

WASHINGTON, Jan. 29, 2025 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the fourth quarter and…

1 year ago

Ocean Biomedical Advances Malaria Vaccine Research with New NIH Funding and Expedited Development Pathway

Providence, RI, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Ocean Biomedical (NASDAQ: OCEA) announced today that its Scientific Co-founder, Dr. Jonathan…

1 year ago

HealthTab™ and Patients Know Best® Bring Pharmacy-Based Blood Test Results to Millions in UK

VANCOUVER, British Columbia, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”)…

1 year ago

XORTX to Present at Microcap Conference

CALGARY, Alberta, Jan. 29, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX…

1 year ago

Transmission Electron Microscope Market to grow by USD 528.8 Million (2024-2028), driven by nanotechnology focus, AI-driven market transformation – Technavio

NEW YORK, Jan. 28, 2025 /PRNewswire/ -- Report with the AI impact on market trends - The global transmission electron microscope…

1 year ago

Cooper University Health Care Breaks Ground on First Phase of $3 Billion “Project Imagine” Expansion in Camden

Camden, New Jersey--(Newsfile Corp. - January 28, 2025) - Today, Cooper University Health Care held a groundbreaking ceremony on the…

1 year ago

Jiva Technologies Announces the Launch of www.LIV3Health.com, Kicking Off Presale Orders for Revolutionary SugarShield Supplement

VANCOUVER, BC, Jan. 28, 2025 /PRNewswire/ -- Jiva Technologies (CSE: JIVA) (Frankfurt: WNT1) (OTCQB: PLTXF) ("JIVA" or the "Company"), a…

1 year ago

Sera Prognostics to Host Virtual R&D Day on January 31

Event will showcase results of Company's pivotal PRIME study and include the principal investigator SALT LAKE CITY, Jan. 27, 2025…

1 year ago

Hemostemix Up-lists to TradeGateExchange in Germany

Calgary, Alberta--(Newsfile Corp. - January 27, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company")…

1 year ago